Cargando…

Bacteria-engineered porous sponge for hemostasis and vascularization

BACKGROUND: Hemostasis and repair are two essential processes in wound healing, yet early hemostasis and following vascularization are challenging to address in an integrated manner. RESULTS: In this study, we constructed a hemostatic sponge OBNC-DFO by fermentation of Komagataeibacter xylinus combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bian, Jie, Bao, Luhan, Gao, Xiaokang, Wen, Xiao, Zhang, Qiang, Huang, Jinhua, Xiong, Zhenghui, Hong, Feng F., Ge, Zili, Cui, Wenguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780714/
https://www.ncbi.nlm.nih.gov/pubmed/35062972
http://dx.doi.org/10.1186/s12951-022-01254-7
_version_ 1784637912865832960
author Bian, Jie
Bao, Luhan
Gao, Xiaokang
Wen, Xiao
Zhang, Qiang
Huang, Jinhua
Xiong, Zhenghui
Hong, Feng F.
Ge, Zili
Cui, Wenguo
author_facet Bian, Jie
Bao, Luhan
Gao, Xiaokang
Wen, Xiao
Zhang, Qiang
Huang, Jinhua
Xiong, Zhenghui
Hong, Feng F.
Ge, Zili
Cui, Wenguo
author_sort Bian, Jie
collection PubMed
description BACKGROUND: Hemostasis and repair are two essential processes in wound healing, yet early hemostasis and following vascularization are challenging to address in an integrated manner. RESULTS: In this study, we constructed a hemostatic sponge OBNC-DFO by fermentation of Komagataeibacter xylinus combined with TEMPO oxidation to obtain oxidized bacterial nanocellulose (OBNC). Then angiogenetic drug desferrioxamine (DFO) was grafted through an amide bond, and it promoted clot formation and activated coagulation reaction by rapid blood absorption due to the high total pore area (approximately 42.429 m(2)/g measured by BET). The further release of DFO stimulated the secretion of HIF-1α and the reconstruction of blood flow, thus achieving rapid hemostasis and vascularization in damaged tissue. This new hemostatic sponge can absorb water at a rate of approximate 1.70 g/s, rapidly enhancing clot formation in the early stage of hemostasis. In vitro and in vivo coagulation experiments (in rat tail amputation model and liver trauma model) demonstrated superior pro-coagulation effects of OBNC and OBNC-DFO to clinically used collagen hemostatic sponges (COL). They promoted aggregation and activation of red blood cells and platelets with shorter whole blood clotting time, more robust activation of endogenous coagulation pathways and less blood loss. In vitro cellular assays showed that OBNC-DFO prevailed over OBNC by promoting the proliferation of human umbilical vein endothelial cells (HUVECs). In addition, the release of DFO enhanced the secretion of HIF-1α, further strengthening vascularization in damaged skin. In the rat skin injury model, 28 days after being treated with OBNC-DFO, skin appendages (e.g., hair follicles) became more intact, indicating the achievement of structural and functional regeneration of the skin. CONCLUSION: This hemostatic and vascularization-promoting oxidized bacterial nanocellulose hemostatic sponge, which rapidly activates coagulation pathways and enables skin regeneration, is a highly promising hemostatic and pro-regenerative repair biomaterial. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01254-7.
format Online
Article
Text
id pubmed-8780714
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87807142022-01-21 Bacteria-engineered porous sponge for hemostasis and vascularization Bian, Jie Bao, Luhan Gao, Xiaokang Wen, Xiao Zhang, Qiang Huang, Jinhua Xiong, Zhenghui Hong, Feng F. Ge, Zili Cui, Wenguo J Nanobiotechnology Research BACKGROUND: Hemostasis and repair are two essential processes in wound healing, yet early hemostasis and following vascularization are challenging to address in an integrated manner. RESULTS: In this study, we constructed a hemostatic sponge OBNC-DFO by fermentation of Komagataeibacter xylinus combined with TEMPO oxidation to obtain oxidized bacterial nanocellulose (OBNC). Then angiogenetic drug desferrioxamine (DFO) was grafted through an amide bond, and it promoted clot formation and activated coagulation reaction by rapid blood absorption due to the high total pore area (approximately 42.429 m(2)/g measured by BET). The further release of DFO stimulated the secretion of HIF-1α and the reconstruction of blood flow, thus achieving rapid hemostasis and vascularization in damaged tissue. This new hemostatic sponge can absorb water at a rate of approximate 1.70 g/s, rapidly enhancing clot formation in the early stage of hemostasis. In vitro and in vivo coagulation experiments (in rat tail amputation model and liver trauma model) demonstrated superior pro-coagulation effects of OBNC and OBNC-DFO to clinically used collagen hemostatic sponges (COL). They promoted aggregation and activation of red blood cells and platelets with shorter whole blood clotting time, more robust activation of endogenous coagulation pathways and less blood loss. In vitro cellular assays showed that OBNC-DFO prevailed over OBNC by promoting the proliferation of human umbilical vein endothelial cells (HUVECs). In addition, the release of DFO enhanced the secretion of HIF-1α, further strengthening vascularization in damaged skin. In the rat skin injury model, 28 days after being treated with OBNC-DFO, skin appendages (e.g., hair follicles) became more intact, indicating the achievement of structural and functional regeneration of the skin. CONCLUSION: This hemostatic and vascularization-promoting oxidized bacterial nanocellulose hemostatic sponge, which rapidly activates coagulation pathways and enables skin regeneration, is a highly promising hemostatic and pro-regenerative repair biomaterial. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01254-7. BioMed Central 2022-01-21 /pmc/articles/PMC8780714/ /pubmed/35062972 http://dx.doi.org/10.1186/s12951-022-01254-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Bian, Jie
Bao, Luhan
Gao, Xiaokang
Wen, Xiao
Zhang, Qiang
Huang, Jinhua
Xiong, Zhenghui
Hong, Feng F.
Ge, Zili
Cui, Wenguo
Bacteria-engineered porous sponge for hemostasis and vascularization
title Bacteria-engineered porous sponge for hemostasis and vascularization
title_full Bacteria-engineered porous sponge for hemostasis and vascularization
title_fullStr Bacteria-engineered porous sponge for hemostasis and vascularization
title_full_unstemmed Bacteria-engineered porous sponge for hemostasis and vascularization
title_short Bacteria-engineered porous sponge for hemostasis and vascularization
title_sort bacteria-engineered porous sponge for hemostasis and vascularization
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780714/
https://www.ncbi.nlm.nih.gov/pubmed/35062972
http://dx.doi.org/10.1186/s12951-022-01254-7
work_keys_str_mv AT bianjie bacteriaengineeredporousspongeforhemostasisandvascularization
AT baoluhan bacteriaengineeredporousspongeforhemostasisandvascularization
AT gaoxiaokang bacteriaengineeredporousspongeforhemostasisandvascularization
AT wenxiao bacteriaengineeredporousspongeforhemostasisandvascularization
AT zhangqiang bacteriaengineeredporousspongeforhemostasisandvascularization
AT huangjinhua bacteriaengineeredporousspongeforhemostasisandvascularization
AT xiongzhenghui bacteriaengineeredporousspongeforhemostasisandvascularization
AT hongfengf bacteriaengineeredporousspongeforhemostasisandvascularization
AT gezili bacteriaengineeredporousspongeforhemostasisandvascularization
AT cuiwenguo bacteriaengineeredporousspongeforhemostasisandvascularization